- Calcium-sensing receptor stimulation in mesenteric artery endothelial cells
S. Carlton-Carew, D. Khan, H. Greenberg, A. Albert. St George's, University of London, London, United Kingdom
- Can H2-histamine receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine?
S. Allen1, J. Dixon1, P. L. Chazot2, R. Abuhamdah3. 1Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom, 2Department of Biosciences, Durham University, Durham, United Kingdom, 3Imperial College London, -, United Kingdom
- Can histone deacetylase inhibitors uncover novel therapeutic agents for inherited retinal dystrophies
H. Sundaramurthi1, H. Rueckert2, A. Moran1, A. Reynolds3, B. Kennedy1. 1Conway Institute, University College Dublin, Dublin, Ireland, 2Temple University, Philadelphia, 3UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland
- Cannabis extract and morphine: a pilot study on analgesia and respiration
K. Taheri, J. Padam, C. Bayley, B. A. MacLeod, E. Puil. Anesthesiology, Pharmacology, & Therapeutics, University of British Columbia, Vancouver, Canada
- Capturing new BIA 10-2474 molecular data in the IUPHAR/BPS Guide to PHARMACOLOGY
C. Southan1, E. Faccenda1, S. D. Harding1, J. L. Sharman1, A. J. Pawson1, S. P. Alexander2, J. A. Davies1. 1IUPHAR/BPS Guide to PHARMACOLOGY, Edinburgh, United Kingdom, 2Molecular Pharmacology, University of Nottingham Medical School, Nottingham, United Kingdom
- Characterisation of a novel delta opioid receptor (DOPr) ligand with improved therapeutic profile
A. Conibear1, M. J. Asghar2, D. Kendall3, B. von Mentzer4, E. Kelly1. 1School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom, 2School of Life Sciences, University of Nottingham, Nottingham, United Kingdom, 3PharmNovo UK Ltd, Liverpool, United Kingdom, 4PharmNovo AB, ™cker”, Sweden
- Characterisation of a novel mouse model of diabetes
A. Roberts1, A. L. Austin1, M. Kennard1, C. Gentry2, S. Sharp2, D. Andersson2, S. Bevan2, P. M. Jones1, A. J. King1. 1Diabetes and Nutritional Sciences, KING'S COLLEGE LONDON, LONDON, United Kingdom, 2Wolfson Centre for Age-Related Diseases, KING'S COLLEGE LONDON, LONDON, United Kingdom
- Characterisation of a novel rat model of Parkinson's disease involving a small-molecule inducer of α-synuclein oligomerisation and a viral mimetic
L. Olsen1, A. Cairns2, J. Aden2, N. Moriarty1, S. Cabre1, V. Alamilla1, F. Almqvist2, E. Dowd1, D. McKernan1. 1Pharmacology & Therapeutics, National University of Ireland, Galway, Galway, Ireland, 2Chemistry, Umea University, Ume†, Sweden
- Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a potent and selective P2Y2 antagonist
M. O. Muoboghare, R. Drummond, C. Kennedy. SIPBS, University of strathclyde, Glasgow, United Kingdom
- Characterising a panel of rare CF-causing mutations
E. Langron1, S. Prins1, C. Hastings2, P. Vergani1. 1Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom, 2CoMPLEX, University College London, London, United Kingdom